A Study to Find and Confirm the Dose and Assess Safety, Reactogenicity and Immune Response of a Vaccine Against Pandemic H5N1 Influenza Virus in Healthy Younger and Older Adults

NCT06382311 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

991

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza, Human

Interventions

BIOLOGICAL: Flu Pandemic mRNA_Dose level 1
BIOLOGICAL: Flu Pandemic mRNA_Dose level 2
BIOLOGICAL: Flu Pandemic mRNA_ Dose level 3.
BIOLOGICAL: Flu Pandemic mRNA_ Dose level 4
BIOLOGICAL: Flu Pandemic mRNA_Dose level 5
BIOLOGICAL: Flu Pandemic mRNA_Dose level 6
BIOLOGICAL: Influenza virus vaccine
DRUG: Placebo

Sponsor

GlaxoSmithKline